医学
内科学
耐受性
三阴性乳腺癌
肿瘤科
转移性乳腺癌
乳腺癌
不利影响
临床研究阶段
癌症
胃肠病学
化疗
作者
Aditya Bardia,Ian E. Krop,Takahiro Kogawa,Dejan Juric,Anthony W. Tolcher,Erika Hamilton,Toru Mukohara,Aaron Lisberg,Toshio Shimizu,Alexander I. Spira,Junji Tsurutani,Senthil Damodaran,Kyriakos P. Papadopoulos,Jonathan Greenberg,Fumiaki Kobayashi,Hong Zebger‐Gong,Rie Wong,Yui Kawasaki,Tadakatsu Nakamura,Funda Meric‐Bernstam
摘要
In patients with heavily pretreated advanced HR+/HER2- BC and TNBC, Dato-DXd demonstrated promising clinical activity and a manageable safety profile. Dato-DXd is currently being evaluated in phase III studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
OsamaKareem
GingerF
Richard
Nexus
无极微光
lalala
MchemG
eric888
互助
未来科研大牛
干净的琦
贪玩的秋柔
嘉心糖
XQQDD
YifanWang
愔愔
Hayat
arniu2008
初景
勤劳赛凤
皖公网安备34019202002308
